ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,022,332 | -13.4% | 5,034,171 | -10.7% | 0.06% | -22.2% |
| Q2 2023 | $20,811,489 | -5.7% | 5,639,970 | -15.4% | 0.07% | -7.7% |
| Q1 2023 | $22,061,220 | +240244.5% | 6,665,021 | +181.7% | 0.08% | +136.4% |
| Q4 2022 | $9,179 | -99.6% | 2,365,720 | +121.6% | 0.03% | +230.0% |
| Q3 2022 | $2,595,000 | +20.4% | 1,067,747 | -2.0% | 0.01% | +25.0% |
| Q2 2022 | $2,156,000 | +134.1% | 1,089,107 | +116.4% | 0.01% | +166.7% |
| Q1 2022 | $921,000 | +397.8% | 503,400 | +283.0% | 0.00% | +200.0% |
| Q4 2021 | $185,000 | +101.1% | 131,444 | +61.2% | 0.00% | – |
| Q3 2021 | $92,000 | -8.0% | 81,545 | +30.7% | 0.00% | – |
| Q2 2021 | $100,000 | -26.5% | 62,376 | -19.2% | 0.00% | -100.0% |
| Q1 2021 | $136,000 | -88.8% | 77,187 | -81.3% | 0.00% | -87.5% |
| Q2 2020 | $1,209,000 | – | 412,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |